Supplemental Data for A Phase II Study of Talazoparib Tosylate in Advanced Cancer Patients with Somatic and Germline (Not Breast or Ovarian Cancer) Alterations of BRCA1/2, Mutations/Deletions/Amplification in Other Homologous Recombination Repair Pathway Genes and PTEN or PTEN loss

Authors

Sarina A. Piha-Paul, The University of Texas MD Anderson Cancer Center
Chieh Tseng, The University of Texas MD Anderson Cancer Center
Cheuk Hong Leung, The University of Texas MD Anderson Cancer Center
Ying Yuan, The University of Texas MD Anderson Cancer Center
Daniel D. Karp, The University of Texas MD Anderson Cancer Center
Vivek Subbiah, The University of Texas MD Anderson Cancer Center
David Hong, The University of Texas MD Anderson Cancer Center
Siqing Fu, The University of Texas MD Anderson Cancer Center
Aung Naing, The University of Texas MD Anderson Cancer Center
Jordi Rodon, The University of Texas MD Anderson Cancer Center
Milind Javle, The University of Texas MD Anderson Cancer Center
Jaffer Ajani, The University of Texas MD Anderson Cancer Center
Kanwal Raghav, The University of Texas MD Anderson Cancer Center
Neeta Somaiah, The University of Texas MD Anderson Cancer Center
Gordon B. Mills, Knight Cancer Institute
Apostolia Tsimberidou, The University of Texas MD Anderson Cancer Center
Xiaofeng Zheng, The University of Texas MD Anderson Cancer Center
Ken Chen, The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center

Files

Data Availability

The de-identified participant data and dataset generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Custom code that was used in the generation or analysis of the datasets is available upon reasonable request.

Corresponding Author: Sarina Piha-Paul,Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX. Phone: (713)-563-1055, Fax:(713)-792-3535, spihapau@mdanderson.org.

DOI

https://doi.org/10.52519/00133

Publication Date

6-2024

Publisher

The University of Texas MD Anderson Cancer Center

Recommended Citation

Piha-Paul, Sarina A.; Tseng, Chieh; Hong Leung, Cheuk; Yuan, Ying; Karp, Daniel D.; Subbiah, Vivek; Hong, David; Fu, Siqing; Naing, Aung; Rodon, Jordi; Javle, Milind; Ajani, Jaffer; Raghav, Kanwal; Somaiah, Neeta; Mills, Gordon B.; Tsimberidou, Apostolia; Zheng, Xiaofeng; Chen, Ken; and Meric-Bernstam, Funda, "Supplemental Data for A Phase II Study of Talazoparib Tosylate in Advanced Cancer Patients with Somatic and Germline (Not Breast or Ovarian Cancer) Alterations of BRCA1/2, Mutations/Deletions/Amplification in Other Homologous Recombination Repair Pathway Genes and PTEN or PTEN loss" (2024). Division of Investigational Cancer Therapeutics. 1.
doi:https://doi.org/10.52519/00133